| Guardant Health, Inc. | 640K | US$96.1M | 5.4% |
| Mirum Pharmaceuticals, Inc. | 530K | US$62.1M | 3.5% |
| Kymera Therapeutics, Inc. | 503K | US$57.7M | 3.2% |
| Abivax Sa | 395K | US$52.6M | 2.9% |
| Trevi Therapeutics, Inc. | 2.66M | US$49.6M | 2.8% |
| Mbx Biosciences, Inc. | 873K | US$48.2M | 2.7% |
| Vaxcyte, Inc. | 828K | US$48.1M | 2.7% |
| Cytokinetics, Incorporated | 564K | US$48M | 2.7% |
| Argenx Se | 49,193 | US$45.6M | 2.6% |
| Ionis Pharmaceuticals, Inc. | 575K | US$45.6M | 2.5% |
| Insmed Incorporated | 403K | US$43M | 2.4% |
| Revolution Medicines, Inc. | 225K | US$42.2M | 2.4% |
| Immix Biopharma, Inc. | 3.89M | US$40.1M | 2.2% |
| Celldex Therapeutics, Inc. | 1.04M | US$38.6M | 2.2% |
| Palvella Therapeutics, Inc. | 231K | US$35.4M | 2.0% |
| Kestra Medical Technologies, Ltd. | 1.37M | US$34.8M | 1.9% |
| Scholar Rock Holding Corporation | 633K | US$34.8M | 1.9% |
| Apogee Therapeutics, Inc. | 260K | US$34.5M | 1.9% |
| Definium Therapeutics, Inc. | 710K | US$33.4M | 1.9% |
| Irhythm Holdings, Inc. | 278K | US$33M | 1.8% |
| Bridgebio Pharma, Inc. | 437K | US$32.6M | 1.8% |
| Beta Bionics, Inc. | 2.05M | US$32.2M | 1.8% |
| Nurix Therapeutics, Inc. | 1.3M | US$31.5M | 1.8% |
| Arrowhead Pharmaceuticals, Inc. | 370K | US$30.2M | 1.7% |
| Disc Medicine, Inc. | 395K | US$28.9M | 1.6% |
| Cg Oncology, Inc. | 366K | US$26M | 1.5% |
| Amylyx Pharmaceuticals, Inc. | 1.32M | US$23.8M | 1.3% |
| Oruka Therapeutics, Inc. | 240K | US$22.8M | 1.3% |
| Dianthus Therapeutics, Inc. | 225K | US$22M | 1.2% |
| Sionna Therapeutics, Inc. | 475K | US$20.9M | 1.2% |
| Celcuity Inc. | 196K | US$20.5M | 1.1% |
| Glaukos Corporation | 143K | US$19.9M | 1.1% |
| Sutro Biopharma, Inc. | 585K | US$19.4M | 1.1% |
| Privia Health Group, Inc. | 738K | US$19M | 1.1% |
| Eyepoint, Inc. | 1.25M | US$17.8M | 1.00% |
| Spyre Therapeutics, Inc. | 200K | US$17.8M | 0.99% |
| Heartflow, Inc. | 595K | US$17.5M | 0.98% |
| Dexcom, Inc. | 253K | US$17M | 0.95% |
| Aktis Oncology, Inc. | 507K | US$16.3M | 0.91% |
| Achieve Life Sciences, Inc. | 2.22M | US$14.5M | 0.81% |
| United Therapeutics Corporation | 26,569 | US$14.4M | 0.80% |
| Axsome Therapeutics, Inc. | 56,024 | US$13.7M | 0.77% |
| Kailera Therapeutics, Inc. | 617K | US$13.6M | 0.76% |
| Praxis Precision Medicines, Inc. | 38,307 | US$12.8M | 0.72% |
| Tango Therapeutics, Inc. | 400K | US$12.5M | 0.70% |
| Evommune, Inc. | 940K | US$12.5M | 0.70% |
| Oric Pharmaceuticals, Inc. | 951K | US$10.3M | 0.58% |
| Bright Minds Biosciences Inc. | 130K | US$9.13M | 0.51% |
| Kardigan, Inc. | 300K | US$7.16M | 0.40% |
| Relmada Therapeutics, Inc. | 1.02M | US$7.03M | 0.39% |
| Inhibrx Biosciences, Inc. | 61,545 | US$5.83M | 0.33% |
| Transmedics Group, Inc. | 82,628 | US$5.49M | 0.31% |
| Ovid Therapeutics Inc. | 1.93M | US$5.2M | 0.29% |
| Avalyn Pharma Inc. | 100K | US$3.29M | 0.18% |
| Ideaya Biosciences, Inc. | 65,000 | US$2.42M | 0.14% |
| Edgewise Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Collegium Pharmaceutical, Inc. | 0 | US$0 | 0.00% |
| Evolent Health, Inc | 0 | US$0 | 0.00% |
| Genedx Holdings Corp. | 0 | US$0 | 0.00% |
| Oculis Holding Ag | 0 | US$0 | 0.00% |
| Castle Biosciences, Inc. | 0 | US$0 | 0.00% |
| Cybin, Inc. | 0 | US$0 | 0.00% |
| Cytomx Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Adc Therapeutics Sa | 0 | US$0 | 0.00% |
| Corvus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Invivyd, Inc. | 0 | US$0 | 0.00% |